Trials / Completed
CompletedNCT00572091
Aachen Safety and Efficacy of the Percutaneous Transvenous Mitral Annuloplasty Device to Reduce Mitral Regurgitation
An Open-Label, Single-Arm Pilot Study of the Safety and Efficacy of the Percutaneous Transvenous Mitral Annuloplasty Device Used to Reduce Mitral Regurgitation
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 4 (actual)
- Sponsor
- Viacor · Industry
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
Improvement in heart failure with moderate to severe mitral regurgitation using a percutaneously delivered implanted device
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | PTMA Implant | Percutaneous assessment from right or left subclavian vein, with PTMA implant in the coronary sinus, great cardiac vein. |
Timeline
- Start date
- 2007-02-01
- Primary completion
- 2008-04-01
- Completion
- 2008-11-01
- First posted
- 2007-12-12
- Last updated
- 2008-11-06
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00572091. Inclusion in this directory is not an endorsement.